fda announcement tirzepatide Diabetes Drug - Gets Approval for Weight Loss FDA approves Eli Lilly's diabetes

GLP-1 medications can be powerful tools for weight and metabolic health, but they also quietly increase the risk of micronutrient deficiencies

This neuroprotective effect of semaglutide may be regionally and time dependent

Eli Lilly will significantly increase the price of its weight-loss drug Mounjaro in the United Kingdom in a bid to bring down prices in the United States after weeks of pressure from the Trump administration.

A new study has found that for people with type 2 diabetes, new use of semaglutide which is also a popular weight loss drug was linked with a lower risk of needing medical care for tobacco use disorder (TUD).

Complete ELISA solutions for biologic development in anti-drug antibody (ADA) detection and other applications.

Most people experience their first semaglutide side effects within 24 to 48 hours of the initial injection, with nausea being the most common reaction